Evidence map›Paper›PMID 34386533›Full record

ArticleFrontiers in cardiovascular medicine2021

IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial.

Renata Moll-Bernardes, Andrea Silvestre de Sousa, Ariane V S Macedo, Renato D Lopes, Narendra Vera, Luciana C R Maia, André Feldman, Guilherme D A S Arruda, Mauro J C Castro, Pedro M Pimentel-Coelho and 14 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Cytokine Profiling in Different SARS-CoV-2 Genetic Variants.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 7 institutions in 2 countries.

Renata Moll-BernardesD'Or Institute for Research and Education, Rio de Janeiro, Brazil.
Andrea Silvestre de SousaD'Or Institute for Research and Education, Rio de Janeiro, Brazil.
Ariane V S MacedoD'Or Institute for Research and Education, Rio de Janeiro, Brazil.
Renato D LopesD'Or Institute for Research and Education, Rio de Janeiro, Brazil.
Narendra VeraInstitute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Luciana C R MaiaInstitute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
André FeldmanD'Or Institute for Research and Education, Rio de Janeiro, Brazil.
Guilherme D A S ArrudaHospital São Luiz São Caetano, São Caetano do Sul, Brazil.
Mauro J C CastroInstituto de Microbiologia Paulo de Góes, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Pedro M Pimentel-CoelhoInstitute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Denílson C de AlbuquerqueD'Or Institute for Research and Education, Rio de Janeiro, Brazil.
Thiago Ceccatto de PaulaHospital São Luiz Jabaquara, São Paulo, Brazil.
Thyago A B FurquimHospital Sino Brasileiro, Osasco, Brazil.
Vitor A LouresHospital São Luiz Anália Franco, São Paulo, Brazil.
Karla G D GiustiHospital Villa Lobos, São Paulo, Brazil.
Nathália M de OliveiraHospital Villa Lobos, São Paulo, Brazil.
Fábio A De LucaHospital São Luiz Morumbi, São Paulo, Brazil.
Marisol D M KotsugaiHospital São Luiz Morumbi, São Paulo, Brazil.
Rafael A M DomicianoHospital São Luiz Anália Franco, São Paulo, Brazil.
Mayara Fraga SantosD'Or Institute for Research and Education, Rio de Janeiro, Brazil.
Olga Ferreira de SouzaD'Or Institute for Research and Education, Rio de Janeiro, Brazil.
Fernando A BozzaD'Or Institute for Research and Education, Rio de Janeiro, Brazil.
Ronir Raggio LuizD'Or Institute for Research and Education, Rio de Janeiro, Brazil.
Emiliano MedeiD'Or Institute for Research and Education, Rio de Janeiro, Brazil.
D’Or Institute for Research and Education · BRHospital São Paulo · BRUniversidade Federal do Rio de Janeiro · BRFundação Oswaldo Cruz · BRFundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro · BRUniversidade do Estado do Rio de Janeiro · BRUniversidade Municipal de São Caetano do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerCOVID-19cytokinehypertensioninflammationprognosis

Identifiers

PMID34386533
PMCPMC8353079
OpenAlexW3185312919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.